Background: DiGeorge syndrome (also known as velo-cardio-facial syndrome) is a rare multisystem genetic disorder occurring in approximately 1 in 4000 to 1 in 6000 live births [1]. Although advances in genetic screening have improved diagnosis in developed countries, the condition remains underdiagnosed in developing nations such as the Republic of Moldova, where access to genetic testing and family planning services is limited. Routine prenatal screening usually includes regular ultrasounds, monitoring of blood pressure, complete blood counts, coagulation studies, glucose, urine protein, and urine culture. Current ultrasound techniques have limitations in detecting this syndrome due to variability in interpretation, and genetic testing is often performed based on clinical discretion. The ultrasound could potentially point towards a genetic problem, as in DiGeorge, if multiple cardiac malformations are spotted in utero, but most cases such as this one are diagnosed after birth while being described as totally normal on prenatal ultrasound. Purpose: This study aims to highlight the diagnostic challenges and the need for comprehensive evaluation in identifying DiGeorge syndrome, emphasizing the importance of considering the syndrome as a whole rather than focusing on isolated organ system issues. Method: We present a case report of a 6-month-old girl who, after an uneventful pregnancy and normal prenatal ultrasound, presented with cardiac insufficiency. Following extensive investigations and multiple surgical interventions, DiGeorge syndrome was diagnosed at 9 months of age. Results: The patient’s diagnosis was delayed due to the lack of prenatal markers and the reliance on separate investigations of affected organ systems. Despite several interventions aimed at managing her symptoms, the final diagnosis was made after observing the association of multiple clinical features and conducting comprehensive genetic testing. Conclusions: This case underscores the importance of a holistic approach to diagnosis, which involves a thorough patient history, integration of diverse diagnostic tests, and recognition of the syndrome’s multi-system nature. It highlights the necessity for improved diagnostic protocols and increased awareness in regions with limited access to advanced genetic testing to prevent delays in identifying DiGeorge syndrome and to facilitate timely and appropriate management.
Butts, S.C. (2009) The Facial Phenotype of the Velo-Cardio-Facial Syndrome. International Journal of Pediatric Otorhinolaryngology, 73, 343-350. https://doi.org/10.1016/j.ijporl.2008.10.011
[3]
Patel, K., Akhter, J., Kobrynski, L., Gathman, B., Davis, O. and Sullivan, K.E. (2012) Immunoglobulin Deficiencies: The B-Lymphocyte Side of Digeorge Syndrome. The Journal of Pediatrics, 161, 950-953. https://doi.org/10.1016/j.jpeds.2012.06.018
[4]
Jawad, A.F., McDonald-McGinn, D.M., Zackai, E. and Sullivan, K.E. (2001) Immunologic Features of Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome). The Journal of Pediatrics, 139, 715-723. https://doi.org/10.1067/mpd.2001.118534
[5]
Cascella, M. and Muzio, M.R. (2015) Early Onset Intellectual Disability in Chromosome 22q11.2 Deletion Syndrome. RevistaChilena de Pediatría, 86, 283-286. https://doi.org/10.1016/j.rchipe.2015.06.019
[6]
Cioffi, S., Martucciello, S., Fulcoli, F.G., Bilio, M., Ferrentino, R., Nusco, E., et al. (2013) Tbx1 Regulates Brain Vascularization. Human Molecular Genetics, 23, 78-89. https://doi.org/10.1093/hmg/ddt400
[7]
Paylor, R., Glaser, B., Mupo, A., Ataliotis, P., Spencer, C., Sobotka, A., et al. (2006) Tbx1 Haploinsufficiency Is Linked to Behavioral Disorders in Mice and Humans: Implications for 22q11 Deletion Syndrome. Proceedings of the National Academy of Sciences, 103, 7729-7734. https://doi.org/10.1073/pnas.0600206103
[8]
Botto, L.D., May, K., Fernhoff, P.M., Correa, A., Coleman, K., Rasmussen, S.A., et al. (2003) A Population-Based Study of the 22q11.2 Deletion: Phenotype, Incidence, and Contribution to Major Birth Defects in the Population. Pediatrics, 112, 101-107. https://doi.org/10.1542/peds.112.1.101
[9]
National Clinical Protocol and Protocol Clinic Naţional (2019) IDP Ataxie-Teleangiectazie, Sindromul DiGeorge. https://repository.usmf.md/bitstream/20.500.12710/20135/1/Protocol_clinic_national_IDP_Sindromul_DiGeorge.pdf
van der Spek, J., Groenwold, R.H.H., van der Burg, M. and van Montfrans, J.M. (2015) TREC Based Newborn Screening for Severe Combined Immunodeficiency Disease: A Systematic Review. Journal of Clinical Immunology, 35, 416-430. https://doi.org/10.1007/s10875-015-0152-6
[15]
Grati, F.R., Molina Gomes, D., Ferreira, J.C.P.B., Dupont, C., Alesi, V., Gouas, L., et al. (2015) Prevalence of Recurrent Pathogenic Microdeletions and Microduplications in over 9500 Pregnancies. Prenatal Diagnosis, 35, 801-809. https://doi.org/10.1002/pd.4613